Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 10:44 a.m. ET with closing information.)
NEW YORK ( TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Tuesday.
Piper Jaffray said investors should avoid Allergan (AGN - Get Report) because of its Restasis drug. Cramer called Allergan "a great American drug company" despite what the analyst says. AGN fell 2.4% to $90.14.Cintas (CTAS - Get Report) issued slightly lower-than-expected guidance. "This is a core, bread and butter, uniform company" and it isn't hiring, Cramer said, which could be saying something about the state of the overall economy. CTAS was down 1.7% to $47.06. Bally Tech (BYI - Get Report) will buy SHFL Entertainment (SHFL) for $1.3 billion. Cramer said it's a great deal and Bally Tech stock would go higher. BYO jumped nearly 7% to end the day at $65.13. Cramer did not have much to say about Deckers Outdoors (DECK), which reports Monday. DECK was up nearly 1% at $57.71. HCA Holdings (HCA - Get Report) has only been "okay" of late, Cramer said. But with admissions trending higher, "if you buy this for next year it could be a home run." HCA closed at $38.86, up 4.4%. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts